| |
| |
|
| Insider
Information: |
Werner Harold R |
| Relationship: |
10% Owner |
| City: |
Princeton |
| State: |
NJ |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
2,646,956 |
|
|
Indirect Shares
|
24,671,815 |
|
|
| Direct
Value |
$8,509,820 |
|
|
|
Indirect Value
|
$24,780,355 |
|
|
| Total
Shares |
27,318,771 |
|
|
| Total
Value |
$33,290,175 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Middlebrook Pharmaceuticals Corp |
MBRKQ |
Director, 10% Owner |
2003-10-15 |
28,550 |
2007-04-12 |
11,863,327 |
Premium* |
|
|
Genvec Inc |
GNVC |
Director |
2006-06-23 |
0 |
2006-06-23 |
3,582,000 |
Premium* |
|
|
Molecular Templates, Inc. |
MTEM |
10% Owner |
2009-10-05 |
0 |
2009-10-05 |
3,041,268 |
Premium* |
|
|
Xencor Inc |
XNCR |
Director |
2013-12-06 |
0 |
2013-12-06 |
1,035,407 |
Premium* |
|
|
Trevena Inc |
TRVN |
10% Owner |
2014-02-05 |
0 |
2014-02-05 |
2,446,251 |
Premium* |
|
|
Globeimmune Inc |
GBIM |
Former 10% Owner |
2014-07-08 |
0 |
2016-02-19 |
554,267 |
Premium* |
|
|
Kineta Ord Shs |
KA |
10% Owner |
2016-02-17 |
0 |
2016-02-17 |
2,149,295 |
Premium* |
|
|
Leap Therapeutics, Inc. |
LPTX |
10% Owner |
2017-01-20 |
2,618,406 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LPTX |
Leap Therapeutics, Inc. |
10% Owner |
– – • |
2017-01-20 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,618,406 |
|
- |
|
| GBIM |
Globeimmune Inc |
Former 10% Owner |
– – – |
2016-02-19 |
4 |
S |
$1.39 |
$6,950 |
I/I |
(5,000) |
554,267 |
0 |
- |
|
| GBIM |
Globeimmune Inc |
Former 10% Owner |
– – – |
2016-02-18 |
4 |
S |
$1.40 |
$7,000 |
I/I |
(5,000) |
559,267 |
0 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-02-17 |
4 |
A |
$0.00 |
$0 |
I/I |
1,774,295 |
1,774,295 |
0 |
- |
|
| KA |
Kineta Ord Shs |
10% Owner |
– – • |
2016-02-17 |
4 |
B |
$8.00 |
$3,000,000 |
I/I |
375,000 |
2,149,295 |
1.5 |
- |
|
| GBIM |
Globeimmune Inc |
Former 10% Owner |
– – – |
2016-02-17 |
4 |
S |
$1.53 |
$7,650 |
I/I |
(5,000) |
564,267 |
0 |
- |
|
| GBIM |
Globeimmune Inc |
10% Owner |
– – • |
2016-02-16 |
4 |
S |
$1.51 |
$7,550 |
I/I |
(5,000) |
569,267 |
0 |
- |
|
| GBIM |
Globeimmune Inc |
10% Owner |
– – • |
2016-02-12 |
4 |
S |
$1.59 |
$7,950 |
I/I |
(5,000) |
574,267 |
0 |
- |
|
| GBIM |
Globeimmune Inc |
10% Owner |
– – • |
2016-02-11 |
4 |
S |
$1.72 |
$8,600 |
I/I |
(5,000) |
579,267 |
0 |
- |
|
| GBIM |
Globeimmune Inc |
10% Owner |
– – • |
2014-07-08 |
4 |
B |
$10.00 |
$1,900,000 |
I/I |
190,000 |
584,267 |
1.5 |
- |
|
| GBIM |
Globeimmune Inc |
10% Owner |
– – • |
2014-07-08 |
4 |
A |
$0.00 |
$0 |
I/I |
394,267 |
394,267 |
0 |
- |
|
| TRVN |
Trevena Inc |
10% Owner |
– – • |
2014-02-05 |
4 |
B |
$7.00 |
$2,079,406 |
I/I |
297,058 |
2,446,251 |
1.5 |
- |
|
| TRVN |
Trevena Inc |
10% Owner |
– – • |
2014-02-05 |
4 |
A |
$0.00 |
$0 |
I/I |
2,149,193 |
2,149,193 |
0 |
- |
|
| XNCR |
Xencor Inc |
Director |
– • – |
2013-12-06 |
4 |
A |
$0.00 |
$0 |
I/I |
1,035,407 |
1,035,407 |
0 |
- |
|
| MTEM |
Molecular Templates, Inc. |
10% Owner |
– – • |
2009-10-05 |
4 |
B |
$0.00 |
$0 |
I/I |
1,570,680 |
3,041,268 |
1.42 |
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2007-04-12 |
4 |
B |
$2.36 |
$2,127,330 |
I/I |
900,000 |
11,863,327 |
2.25 |
- |
|
| GNVC |
Genvec Inc |
Director |
– • – |
2006-06-23 |
4 |
S |
$1.25 |
$8,568,078 |
I/I |
(6,854,462) |
3,582,000 |
|
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2005-04-29 |
4 |
B |
$3.98 |
$7,000,004 |
I/I |
1,758,795 |
10,963,327 |
2.25 |
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2003-10-22 |
4 |
A |
$0.00 |
$0 |
I/I |
9,162,459 |
9,204,532 |
|
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2003-10-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
13,523 |
|
- |
|
| MBRKQ |
Middlebrook Pharmaceutica... |
Director |
– • • |
2003-10-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
28,550 |
|
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
